結果ページ12 セクター：医療 産業：バイオテクノロジー 株式市場―見積もりと価格
価格、時価総額、PE、EPSを含む全株式と自己資本のリスト
すべての国
- {{country.name}}
- すべての国
- 米国 (656)
- オーストラリア (49)
- オーストリア (11)
- ベルギー (6)
- ブラジル (14)
- カナダ (48)
- 中国 (91)
- デンマーク (5)
- フィンランド (4)
- フランス (27)
- ドイツ (449)
- 香港 (46)
- インド (19)
- イスラエル (12)
- イタリア (3)
- 日本 (37)
- メキシコ (22)
- オランダ (3)
- ニュージーランド (1)
- ノルウェー (10)
- ポーランド (8)
- ロシア (2)
- 韓国 (20)
- スペイン (4)
- スウェーデン (55)
- スイス (8)
- 台湾 (60)
- タイ (2)
- トルコ (1)
- イギリス (24)
全取引所
- {{item.name}}
- 全取引所
- Amsterdam (3)
- ASX (49)
- Brussels (6)
- BSE (9)
- Canadian Sec (21)
- Cboe CA (3)
- Copenhagen (5)
- Frankfurt (395)
- Helsinki (4)
- HKSE (46)
- IOB (24)
- Istanbul (1)
- KOSDAQ (10)
- KSE (10)
- MCE (4)
- MCX (2)
- Mexico (22)
- Milan (3)
- Munich (17)
- NSE (10)
- NYSE (6)
- NYSE American (14)
- NZSE (1)
- Oslo (10)
- OTC Markets EXMKT (41)
- OTC Markets OTCPK (107)
- OTC Markets OTCQB (30)
- OTC Markets OTCQX (6)
- Paris (27)
- São Paulo (14)
- Shanghai (46)
- Shenzhen (45)
- Stockholm (55)
- Stuttgart (24)
- Swiss (8)
- Taipei Exchange (53)
- Taiwan (7)
- Tech Market Large (156)
- Tech Market Middle (85)
- Tech Market Small (211)
- Tel Aviv (12)
- Thailand (2)
- Tokyo (37)
- Toronto (8)
- TSXV (16)
- Vienna (11)
- Warsaw (8)
- XETRA (13)
バイオテクノロジー (1697)
| 名前 名前 | 価格 価格 |
24h% 7d chart 24h% & 7d |
時価総額 時価総額 | 出来高 出来高 | 過去24時間底値 | 過去24時間高値 | 時価総額 | PER (株価収益率) | 1株当たり利益 | 予測 |
|---|
| 名前 名前 | 価格 価格 |
24h% 7d chart 24h% & 7d |
時価総額 時価総額 | 出来高 出来高 | 過去24時間底値 | 過去24時間高値 | 時価総額 | PER (株価収益率) | 1株当たり利益 | 予測 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} |
|
|
| Everest Medicines Limited 6HN.F | €5.10 5.57 USD |
+0.99
|
€1.83B 2.01B USD | €302.00 330.13 USD | €5.10 5.57 USD | €5.10 5.57 USD | €1.83B 2.01B USD | 0 | -€0.25 -0.2 USD | ||
| Galapagos NV GLPG.VI | €26.78 29.27 USD |
0
|
€1.80B 1.97B USD | €0.00 0 USD | €26.62 29.1 USD | €26.78 29.27 USD | €1.80B 1.97B USD | 0 | -€6.74 -7.3 USD | ||
| ImmunityBio, Inc. 26CA.F | €1.82 1.99 USD |
-0.41
|
€1.79B 1.96B USD | €2.79K 3.05K USD | €1.82 1.99 USD | €1.86 2.03 USD | €1.79B 1.96B USD | 0 | -€0.35 -0.3 USD | ||
| Galapagos NV GXE.F | €26.54 29.01 USD |
0
|
€1.79B 1.96B USD | €100.00 109.31 USD | €26.54 29.01 USD | €26.54 29.01 USD | €1.79B 1.96B USD | 0 | -€6.74 -7.3 USD | ||
| Galapagos NV GXEA.F | €26.80 29.3 USD |
0
|
€1.79B 1.95B USD | €230.00 251.42 USD | €26.80 29.3 USD | €26.80 29.3 USD | €1.79B 1.95B USD | 0 | -€6.74 -7.3 USD | ||
| Immunocore Holdings plc 6YG.F | €34.60 37.82 USD |
+0.58
|
€1.78B 1.95B USD | €50.00 54.66 USD | €34.60 37.82 USD | €35.60 38.92 USD | €1.78B 1.95B USD | 0 | -€0.50 -0.5 USD | ||
| Vericel Corporation ATQP.F | €34.40 37.6 USD |
-5.49
|
€1.76B 1.92B USD | €5.00 5.47 USD | €34.40 37.6 USD | €34.40 37.6 USD | €1.76B 1.92B USD | 149.56 | €0.23 0.25 USD | ||
| Galapagos N.V. A GXE.DE | €26.56 29.03 USD |
-0.75
|
€1.75B 1.91B USD | €18.00 19.68 USD | €26.56 29.03 USD | €26.56 29.03 USD | €1.75B 1.91B USD | 0 | -€6.74 -7.3 USD | ||
| Ascletis Pharma ASCLF | $1.77 — |
0
|
$1.82B — | $500.00 — | $1.20 — | $1.20 — | $1.82B — | 0 | -$0.04 — | ||
| Mesoblast MEOBF | $1.35 — |
0
|
$1.73B — | $1.00K — | $1.35 — | $1.35 — | $1.73B — | 0 | -$0.08 — | ||
| Ascletis Pharma Inc. 2VJ.F | €1.59 1.74 USD |
+3.92
|
€1.58B 1.72B USD | €503.00 549.85 USD | €1.56 1.71 USD | €1.59 1.74 USD | €1.58B 1.72B USD | 0 | -€0.03 -0.03 USD | ||
| Stoke Therapeutics, Inc. 0GT.F | €26.60 29.08 USD |
+4.72
|
€1.55B 1.7B USD | €1.00K 1.09K USD | €26.60 29.08 USD | €26.60 29.08 USD | €1.55B 1.7B USD | 45.08 | €0.59 0.64 USD | ||
| Pharvaris N.V. 9EN.F | €23.60 25.8 USD |
-0.84
|
€1.53B 1.68B USD | €30.00 32.79 USD | €23.60 25.8 USD | €23.60 25.8 USD | €1.53B 1.68B USD | 0 | -€2.90 -3.1 USD | ||
| Oxford Nanopore Technologies plc 4R0.F | €1.54 1.68 USD |
-1.16
|
€1.52B 1.66B USD | €1.00K 1.09K USD | €1.50 1.64 USD | €1.54 1.68 USD | €1.52B 1.66B USD | 0 | -€0.17 -0.1 USD | ||
| Celldex Therapeutics, Inc. TCE2.F | €22.80 24.92 USD |
+0.88
|
€1.52B 1.66B USD | €133.00 145.39 USD | €22.80 24.92 USD | €22.80 24.92 USD | €1.52B 1.66B USD | 0 | -€2.92 -3.1 USD | ||
| Agios Pharmaceuticals, Inc. 8AP.F | €24.80 27.11 USD |
+1.64
|
€1.49B 1.63B USD | €100.00 109.31 USD | €24.80 27.11 USD | €24.80 27.11 USD | €1.49B 1.63B USD | 0 | -€6.06 -6.6 USD | ||
| uniQure N.V. UQ1.F | €23.48 25.67 USD |
-2.41
|
€1.46B 1.6B USD | €190.00 207.7 USD | €23.48 25.67 USD | €23.48 25.67 USD | €1.46B 1.6B USD | 0 | -€3.80 -4.1 USD | ||
| Neuren Pharmaceuticals NURPF | $12.25 — |
0
|
$1.57B — | $250.00 — | $12.25 — | $12.25 — | $1.57B — | 16.55 | $0.74 — | ||
| Pharma Mar PHMMF | $86.36 — |
0
|
$1.57B — | $152.00 — | $93.00 — | $93.00 — | $1.57B — | 38.38 | $2.25 — | ||
| Pharma Mar, S.A. 0RC6.IL | €78.25 85.54 USD |
+0.68
|
€1.41B 1.55B USD | €701.00 766.29 USD | €77.10 84.28 USD | €78.95 86.3 USD | €1.41B 1.55B USD | 70.49 | €1.11 1.21 USD | ||
| MannKind Corporation NNFN.F | €4.57 5 USD |
-0.02
|
€1.40B 1.53B USD | €1.91K 2.09K USD | €4.57 5 USD | €4.57 5 USD | €1.40B 1.53B USD | 50.79 | €0.09 0.1 USD | ||
| Biotest Aktiengesellschaft BIO3.F | €30.20 33.01 USD |
+1.34
|
€1.40B 1.53B USD | €600.00 655.88 USD | €29.60 32.36 USD | €30.20 33.01 USD | €1.40B 1.53B USD | 0 | -€0.63 -0.6 USD | ||
| Biotest Aktiengesellschaft BIO.F | €42.20 46.13 USD |
0
|
€1.40B 1.53B USD | €30.00 32.79 USD | €42.20 46.13 USD | €42.20 46.13 USD | €1.40B 1.53B USD | 0 | -€0.63 -0.6 USD | ||
| Biotest Aktiengesellschaft BIO.DE | €42.20 46.13 USD |
-0.94
|
€1.40B 1.53B USD | €175.00 191.3 USD | €42.20 46.13 USD | €43.00 47 USD | €1.40B 1.53B USD | 0 | -€0.63 -0.6 USD | ||
| Innoviva, Inc. HVE.F | €18.50 20.22 USD |
-1.07
|
€1.38B 1.51B USD | €62.00 67.77 USD | €18.50 20.22 USD | €18.50 20.22 USD | €1.38B 1.51B USD | 12.84 | €1.44 1.57 USD | ||
| Pharma Mar, S.A. PMRA.F | €76.80 83.95 USD |
-0.71
|
€1.38B 1.51B USD | €100.00 109.31 USD | €76.80 83.95 USD | €76.80 83.95 USD | €1.38B 1.51B USD | 39.18 | €1.96 2.14 USD | ||
| BioCryst Pharmaceuticals, Inc. BO1.F | €6.07 6.64 USD |
+3.26
|
€1.31B 1.43B USD | €817.00 893.09 USD | €6.07 6.64 USD | €6.07 6.64 USD | €1.31B 1.43B USD | 0 | -€0.04 -0.04 USD | ||
| Vir Biotechnology, Inc. VIR.MX | MX$172.00 10.18 USD |
0
|
MX$23.93B 1.42B USD | MX$0.00 0 USD | MX$172.00 10.18 USD | MX$172.00 10.18 USD | MX$23.93B 1.42B USD | 0 | -MX$78.10 -4.6 USD | ||
| PeptiDream PPTDF | $10.95 — |
0
|
$1.41B — | $100.00 — | $10.24 — | $10.24 — | $1.41B — | 0 | -$0.25 — | ||
| HBM Holdings Limited 6XY.F | €1.50 1.64 USD |
+1.35
|
€1.28B 1.4B USD | €1.00K 1.09K USD | €1.50 1.64 USD | €1.50 1.64 USD | €1.28B 1.4B USD | 18.75 | €0.08 0.09 USD | ||
| Lexicon Pharmaceuticals, Inc. LX31.MU | €3.53 3.86 USD |
0
|
€1.28B 1.39B USD | €250.00 273.28 USD | €3.53 3.86 USD | €3.53 3.86 USD | €1.28B 1.39B USD | 0 | -€0.55 -0.6 USD | ||
| Jubilant Ingrevia Limited JUBLINGREA.NS | ₹711.95 8.61 USD |
-2.34
|
₹112.65B 1.36B USD | ₹285.87K 3.46K USD | ₹707.05 8.55 USD | ₹730.00 8.83 USD | ₹112.65B 1.36B USD | 39.22 | ₹18.15 0.22 USD | ||
| Jubilant Ingrevia Limited JUBLINGREA.BO | ₹711.50 8.61 USD |
-2.34
|
₹112.51B 1.36B USD | ₹9.72K 117.6 USD | ₹707.60 8.56 USD | ₹728.00 8.81 USD | ₹112.51B 1.36B USD | 39.07 | ₹18.21 0.22 USD | ||
| Ardelyx, Inc. 41X.F | €5.07 5.54 USD |
+1.4
|
€1.23B 1.35B USD | €1.40K 1.53K USD | €5.07 5.54 USD | €5.07 5.54 USD | €1.23B 1.35B USD | 0 | -€0.20 -0.2 USD | ||
| CStone Pharmaceuticals CSPHF | $0.89 — |
0
|
$1.34B — | $150.00 — | $1.00 — | $1.00 — | $1.34B — | 0 | -$0.04 — | ||
| SanBio Company SNBIF | $16.45 — |
0
|
$1.32B — | $1.00K — | $3.85 — | $3.85 — | $1.32B — | 0 | -$0.33 — | ||
| UroGen Pharma Ltd. UR8.F | €25.00 27.33 USD |
+6.84
|
€1.21B 1.32B USD | €190.00 207.7 USD | €25.00 27.33 USD | €25.00 27.33 USD | €1.21B 1.32B USD | 0 | -€3.00 -3.2 USD | ||
| CureVac N.V. 0A9E.IL | $5.13 — |
0
|
$1.28B — | $261.00 — | $5.45 — | $5.45 — | $1.28B — | 0 | -$1.50 — | ||
| Precigen, Inc. I5X.F | €3.18 3.48 USD |
+3.45
|
€1.17B 1.28B USD | €2.83K 3.09K USD | €3.18 3.48 USD | €3.18 3.48 USD | €1.17B 1.28B USD | 0 | -€1.23 -1.3 USD | ||
| Atai Beckley N.V. 9VC.F | €3.19 3.49 USD |
-3.3
|
€1.16B 1.27B USD | €3.30K 3.61K USD | €3.19 3.49 USD | €3.27 3.58 USD | €1.16B 1.27B USD | 0 | -€0.72 -0.7 USD | ||
| Maravai LifeSciences Holdings, Inc. MAR.F | €3.10 3.39 USD |
0
|
€1.15B 1.26B USD | €610.00 666.81 USD | €3.10 3.39 USD | €3.10 3.39 USD | €1.15B 1.26B USD | 0 | -€0.73 -0.7 USD | ||
| Nektar Therapeutics NKTR.MX | MX$1,030.00 60.99 USD |
0
|
MX$20.95B 1.24B USD | MX$0.00 0 USD | MX$1,030.00 60.99 USD | MX$1,030.00 60.99 USD | MX$20.95B 1.24B USD | 0 | -MX$180.70 -10.7 USD | ||
| Novavax, Inc. NVAX.MX | MX$125.70 7.44 USD |
0
|
MX$20.48B 1.21B USD | MX$1.00 0.06 USD | MX$125.70 7.44 USD | MX$125.70 7.44 USD | MX$20.48B 1.21B USD | 3.40 | MX$36.97 2.19 USD | ||
| Immatics N.V. 4A3.F | €9.08 9.92 USD |
-3.2
|
€1.11B 1.21B USD | €650.00 710.54 USD | €9.08 9.92 USD | €9.08 9.92 USD | €1.11B 1.21B USD | 0 | -€0.93 -1.01 USD | ||
| Wave Life Sciences Ltd. 1U5.F | €6.60 7.21 USD |
+7.32
|
€1.10B 1.21B USD | €100.00 109.31 USD | €6.60 7.21 USD | €6.60 7.21 USD | €1.10B 1.21B USD | 0 | -€0.56 -0.6 USD | ||
| EyePoint Pharmaceuticals, Inc. PV3B.F | €12.47 13.63 USD |
+2.68
|
€1.09B 1.19B USD | €1.44K 1.57K USD | €12.47 13.63 USD | €12.47 13.63 USD | €1.09B 1.19B USD | 0 | -€2.59 -2.8 USD | ||
| Syndax Pharmaceuticals, Inc. 1T3.F | €12.40 13.55 USD |
0
|
€1.08B 1.18B USD | €4.43K 4.84K USD | €12.40 13.55 USD | €12.40 13.55 USD | €1.08B 1.18B USD | 0 | -€3.11 -3.3 USD | ||
| CureVac N.V. CVAC.VI | €4.66 5.1 USD |
+1
|
€1.06B 1.16B USD | €0.00 0 USD | €4.66 5.09 USD | €4.68 5.12 USD | €1.06B 1.16B USD | 8.18 | €0.57 0.62 USD | ||
| Pharming Group N.V. PHGN.F | €1.53 1.67 USD |
+4.17
|
€1.04B 1.14B USD | €5.00 5.47 USD | €1.53 1.67 USD | €1.53 1.67 USD | €1.04B 1.14B USD | 0 | €0.00 0 USD | ||
| Abbisko Cayman Limited 8ZD.F | €1.54 1.68 USD |
+2.67
|
€1.04B 1.14B USD | €690.00 754.26 USD | €1.54 1.68 USD | €1.54 1.68 USD | €1.04B 1.14B USD | 51.33 | €0.03 0.03 USD | ||
| Xencor, Inc. XE9.F | €14.50 15.85 USD |
0
|
€1.04B 1.13B USD | €80.00 87.45 USD | €14.50 15.85 USD | €14.50 15.85 USD | €1.04B 1.13B USD | 0 | -€1.50 -1.6 USD | ||
| Pharming PHGUF | $1.65 — |
0
|
$1.13B — | $2.00 — | $1.65 — | $1.65 — | $1.13B — | 0 | $0.00 — | ||
| Kodiak Sciences Inc. K27.F | €19.23 21.02 USD |
-0.93
|
€1.02B 1.12B USD | €145.00 158.5 USD | €19.23 21.02 USD | €19.23 21.02 USD | €1.02B 1.12B USD | 0 | -€3.56 -3.8 USD | ||
| Palvella Therapeutics Inc. R PI6.F | €85.50 93.46 USD |
+2.4
|
€1.01B 1.11B USD | €12.00 13.12 USD | €85.50 93.46 USD | €85.50 93.46 USD | €1.01B 1.11B USD | 0 | -€2.52 -2.7 USD | ||
| Xeris Biopharma Holdings, Inc. 2B30.F | €6.10 6.66 USD |
+0.49
|
€1.01B 1.11B USD | €1.44K 1.58K USD | €6.10 6.66 USD | €6.10 6.66 USD | €1.01B 1.11B USD | 0 | -€0.09 -0.09 USD | ||
| Novavax, Inc. NVV1.F | €6.13 6.7 USD |
+2.3
|
€998.46M 1.09B USD | €6.62K 7.24K USD | €6.04 6.6 USD | €6.13 6.7 USD | €998.46M 1.09B USD | 3.52 | €1.74 1.9 USD | ||
| CStone Pharmaceuticals PH4.F | €0.68 0.74 USD |
+6.3
|
€986.24M 1.08B USD | €5.00K 5.47K USD | €0.68 0.74 USD | €0.69 0.75 USD | €986.24M 1.08B USD | 0 | -€0.04 -0.04 USD | ||
| ORIC Pharmaceuticals, Inc. 4TZ.F | €9.95 10.88 USD |
+2.05
|
€982.81M 1.07B USD | €1.00K 1.09K USD | €9.95 10.88 USD | €9.95 10.88 USD | €982.81M 1.07B USD | 0 | -€1.48 -1.6 USD | ||
| MedinCell S.A. MEB.F | €27.90 30.5 USD |
-2.52
|
€935.46M 1.02B USD | €200.00 218.63 USD | €27.90 30.5 USD | €28.68 31.35 USD | €935.46M 1.02B USD | 0 | -€0.62 -0.6 USD | ||
| Oxford Biomedica OXBDF | $8.46 — |
+5.22
|
$1.02B — | $10.00K — | $8.04 — | $8.04 — | $1.02B — | 0 | -$0.48 — | ||
| AbCellera Biologics Inc. 8QQ.F | €3.11 3.4 USD |
-1.05
|
€929.73M 1.02B USD | €710.00 776.13 USD | €3.11 3.4 USD | €3.26 3.56 USD | €929.73M 1.02B USD | 0 | -€0.49 -0.5 USD | ||
| Savara Inc. YB4P.F | €4.54 4.96 USD |
-1.3
|
€923.74M 1.01B USD | €50.00 54.66 USD | €4.54 4.96 USD | €4.54 4.96 USD | €923.74M 1.01B USD | 0 | -€0.46 -0.5 USD | ||
| CK Life Sciences Int'l., (Holdings) Inc. LSI.F | €0.09 0.1 USD |
+1.07
|
€916.62M 1B USD | €0.00 0 USD | €0.09 0.1 USD | €0.09 0.1 USD | €916.62M 1B USD | 0 | €0.00 0 USD | ||
| Theravance Biopharma, Inc. 0TB.F | €17.00 18.58 USD |
+5.59
|
€897.18M 980.74M USD | €115.00 125.71 USD | €17.00 18.58 USD | €17.00 18.58 USD | €897.18M 980.74M USD | 34.69 | €0.49 0.54 USD | ||
| Idorsia IDRSF | $3.95 — |
0
|
$970.59M — | $250.00 — | $4.40 — | $4.40 — | $970.59M — | 0 | -$0.77 — | ||
| Nanobiotix S.A. 5NR.F | €17.46 19.09 USD |
+3.07
|
€880.19M 962.17M USD | €100.00 109.31 USD | €16.30 17.82 USD | €17.72 19.37 USD | €880.19M 962.17M USD | 0 | -€1.09 -1.1 USD | ||
| Oxford Biomedica plc OXOA.F | €7.10 7.76 USD |
0
|
€867.51M 948.3M USD | €250.00 273.28 USD | €7.10 7.76 USD | €7.10 7.76 USD | €867.51M 948.3M USD | 0 | -€0.41 -0.4 USD | ||
| Iovance Biotherapeutics, Inc. 2LB.F | €2.09 2.28 USD |
-0.71
|
€827.68M 904.76M USD | €120.00 131.18 USD | €2.08 2.28 USD | €2.09 2.28 USD | €827.68M 904.76M USD | 0 | -€1.03 -1.1 USD | ||
| Nanobiotix S.A. 5NRA.F | €16.90 18.47 USD |
+0.6
|
€824.05M 900.79M USD | €10.00 10.93 USD | €16.70 18.26 USD | €17.70 19.35 USD | €824.05M 900.79M USD | 0 | -€1.09 -1.1 USD | ||
| Intellia Therapeutics, Inc. 38I.F | €6.99 7.64 USD |
-5.51
|
€809.88M 885.31M USD | €235.00 256.89 USD | €6.99 7.64 USD | €6.99 7.64 USD | €809.88M 885.31M USD | 0 | -€3.67 -4.01 USD | ||
| Seegene, Inc. 096530.KQ | ₩25,150 18.98 USD |
0
|
₩1T 875.4M USD | ₩0 0 USD | ₩0 0 USD | ₩0 0 USD | ₩1T 875.4M USD | 0 | ₩0 0 USD | ||
| GNI Group Ltd. 3G6.F | €13.70 14.98 USD |
0
|
€787.14M 860.46M USD | €500.00 546.57 USD | €13.70 14.98 USD | €13.70 14.98 USD | €787.14M 860.46M USD | 0 | -€0.02 -0.02 USD | ||
| Inventiva IVEVF | $4.44 — |
0
|
$848.12M — | $600.00 — | $4.14 — | $4.50 — | $848.12M — | 0 | -$4.33 — | ||
| GH Research PLC 1KA.F | €12.30 13.45 USD |
-1.6
|
€775.04M 847.23M USD | €13.00 14.21 USD | €12.30 13.45 USD | €12.30 13.45 USD | €775.04M 847.23M USD | 0 | -€0.63 -0.6 USD | ||
| Green Cross Holdings Corporation 005257.KS | ₩24,450 18.46 USD |
0
|
₩1T 837.92M USD | ₩0 0 USD | ₩0 0 USD | ₩0 0 USD | ₩1T 837.92M USD | 0 | ₩0 0 USD | ||
| Pharming Group N.V. PHG.F | €10.90 11.92 USD |
0
|
€762.66M 833.69M USD | €0.00 0 USD | €10.90 11.92 USD | €10.90 11.92 USD | €762.66M 833.69M USD | 0 | €0.00 0 USD | ||
| Gossamer Bio, Inc. 4GB.MU | €2.82 3.08 USD |
+2.1
|
€747.91M 817.57M USD | €0.00 0 USD | €2.82 3.08 USD | €2.82 3.08 USD | €747.91M 817.57M USD | 0 | -€0.79 -0.8 USD | ||
| Arbutus Biopharma Corporation I9DN.F | €3.73 4.07 USD |
+2.08
|
€739.24M 808.09M USD | €2.18K 2.38K USD | €3.73 4.07 USD | €3.73 4.07 USD | €739.24M 808.09M USD | 0 | -€0.20 -0.2 USD | ||
| Raspberry Pi Holdings PLC R 0IK.F | €3.75 4.1 USD |
+1.35
|
€724.97M 792.49M USD | €400.00 437.25 USD | €3.67 4.01 USD | €3.75 4.1 USD | €724.97M 792.49M USD | 93.75 | €0.04 0.04 USD | ||
| Ocumension Therapeutics 5DG.F | €0.88 0.96 USD |
+2.94
|
€704.21M 769.79M USD | €7.00 7.65 USD | €0.88 0.96 USD | €0.88 0.96 USD | €704.21M 769.79M USD | 0 | -€0.04 -0.04 USD | ||
| Inventiva S.A. 6IV.F | €3.67 4.01 USD |
+0.55
|
€701.04M 766.33M USD | €500.00 546.57 USD | €3.67 4.01 USD | €3.67 4.01 USD | €701.04M 766.33M USD | 0 | -€3.76 -4.1 USD | ||
| Pharmicell Co., Ltd. 005690.KS | ₩16,840 12.71 USD |
+2.68
|
₩1T 762.74M USD | ₩0 0 USD | ₩0 0 USD | ₩0 0 USD | ₩1T 762.74M USD | 0 | ₩0 0 USD | ||
| Inventiva S.A. 6IVA.F | €3.58 3.91 USD |
-3.24
|
€683.84M 747.53M USD | €4.00K 4.37K USD | €3.58 3.91 USD | €3.72 4.07 USD | €683.84M 747.53M USD | 0 | -€3.76 -4.1 USD | ||
| Shanghai Haohai Biological Technology Co., Ltd. 5HB.F | €3.00 3.28 USD |
-0.66
|
€681.52M 745M USD | €1.00 1.09 USD | €3.00 3.28 USD | €3.02 3.3 USD | €681.52M 745M USD | 14.28 | €0.21 0.23 USD | ||
| Valneva SE INRLF | $4.26 — |
0
|
$743.84M — | $175.00 — | $4.40 — | $4.40 — | $743.84M — | 0 | -$0.75 — | ||
| Replimune Group, Inc. 7R8.F | €8.35 9.13 USD |
+4.38
|
€678.88M 742.11M USD | €100.00 109.31 USD | €8.35 9.13 USD | €8.35 9.13 USD | €678.88M 742.11M USD | 0 | -€3.00 -3.2 USD | ||
| Supriya Lifescience Limited SUPRIYA.NS | ₹761.75 9.22 USD |
-0.76
|
₹61.31B 741.72M USD | ₹117.61K 1.42K USD | ₹760.00 9.19 USD | ₹778.15 9.41 USD | ₹61.31B 741.72M USD | 33.52 | ₹22.72 0.27 USD | ||
| Supriya Lifescience Limited SUPRIYA.BO | ₹760.50 9.2 USD |
-0.9
|
₹61.21B 740.5M USD | ₹10.39K 125.71 USD | ₹758.70 9.18 USD | ₹776.45 9.39 USD | ₹61.21B 740.5M USD | 33.47 | ₹22.72 0.27 USD | ||
| Gossamer Bio, Inc. 4GB.F | €2.83 3.09 USD |
+0.93
|
€675.30M 738.19M USD | €320.00 349.8 USD | €2.77 3.02 USD | €2.83 3.09 USD | €675.30M 738.19M USD | 0 | -€0.60 -0.6 USD | ||
| CorMedix Inc. 19KA.F | €8.10 8.85 USD |
-0.61
|
€673.05M 735.73M USD | €100.00 109.31 USD | €8.10 8.85 USD | €8.10 8.85 USD | €673.05M 735.73M USD | 4.24 | €1.91 2.09 USD | ||
| Valneva SE AYJ0.F | €7.55 8.25 USD |
-3.21
|
€667.61M 729.79M USD | €120.00 131.18 USD | €7.25 7.93 USD | €7.55 8.25 USD | €667.61M 729.79M USD | 0 | -€1.30 -1.4 USD | ||
| Geron Corporation GON.F | €1.02 1.11 USD |
+3.16
|
€650.48M 711.07M USD | €125.00 136.64 USD | €1.02 1.11 USD | €1.02 1.11 USD | €650.48M 711.07M USD | 0 | -€0.10 -0.1 USD | ||
| Takara Bio Inc. 4974.T | ¥843 5.69 USD |
-0.35
|
¥102B 685.22M USD | ¥144K 968.67 USD | ¥835 5.64 USD | ¥848 5.72 USD | ¥102B 685.22M USD | 0 | -¥53 -0.3 USD | ||
| CytomX Therapeutics, Inc. 6C1.F | €3.57 3.9 USD |
+1.48
|
€626.42M 684.76M USD | €5.25K 5.74K USD | €3.57 3.9 USD | €3.57 3.9 USD | €626.42M 684.76M USD | 13.72 | €0.26 0.28 USD | ||
| Sunmax Biotechnology Co., Ltd. 4728.TWO | NT$390.00 12.39 USD |
0
|
NT$21.24B 674.93M USD | NT$4.16K 132.06 USD | NT$390.00 12.39 USD | NT$390.50 12.41 USD | NT$21.24B 674.93M USD | 29.68 | NT$13.14 0.42 USD | ||
| KalVista Pharmaceuticals, Inc. 4XC1.F | €12.10 13.23 USD |
+8.04
|
€615.90M 673.26M USD | €930.00 1.02K USD | €12.10 13.23 USD | €12.10 13.23 USD | €615.90M 673.26M USD | 0 | -€3.41 -3.7 USD | ||
| Takara Bio Inc. TF2.F | €4.42 4.83 USD |
+1.84
|
€575.23M 628.8M USD | €200.00 218.63 USD | €4.42 4.83 USD | €4.42 4.83 USD | €575.23M 628.8M USD | 0 | -€0.29 -0.3 USD | ||
| Omeros Corporation 3O8.F | €8.11 8.86 USD |
-1.88
|
€574.65M 628.17M USD | €1.08K 1.18K USD | €8.11 8.86 USD | €8.11 8.86 USD | €574.65M 628.17M USD | 0 | -€1.75 -1.9 USD | ||
| REGENXBIO Inc. RB0.F | €11.30 12.35 USD |
-2.59
|
€572.04M 625.32M USD | €700.00 765.19 USD | €11.30 12.35 USD | €11.30 12.35 USD | €572.04M 625.32M USD | 0 | -€2.99 -3.2 USD | ||
| Opthea OPT | $3.41 — |
0
|
$583.10M — | $0.00 — | $0.00 — | $0.00 — | $583.10M — | 0 | $0.00 — | ||
|
お気に入り銘柄なし
お気に入りの株式はまだありません。ここで表示するにはお気に入りに追加してください |
|||||||||||